Biacore Establishes New Technology Supply Division.Business Editors Uppsala, Sweden--(BUSINESS WIRE)--Aug. 14, 2000 Lars-Ake Lejon appointed to head up new unit Biacore International AB (Biacore) (SSE (1) An earlier full-screen editor in OS/2. (2) (Streaming SIMD Extensions) A series of additional instructions built into Pentium CPU chips for improved multimedia performance by performing mathematical operations on multiple sets of data at the : BCOR)(Nasdaq: BCOR) today announces the appointment of Mr Lars-Ake Lejon as Vice President and Head of Technology Supply. His role will be to lead and manage the new Technology Supply division, which will bring together the Company's extensive technical resources in research and development, manufacturing, quality assurance and product management. Mr Lejon joins Biacore from Amersham Pharmacia Biotech where, amongst other roles, he worked as Section Manager in R&D and as a project manager for various drug discovery products. He holds a Master of Science degree in Engineering Physics. "Mr Lejon brings extensive technical and project management experience to Biacore," commented Biacore's President Ulf Jonsson. "His broad experience will help provide focused expertise in developing our new product lines, such as the Company's new high performance systems for late stage drug discovery and new SPR spr Spring SPR Strategic Petroleum Reserve SPR Surface Plasmon Resonance SPR Suomen Punainen Risti SpR Specialist Registrar (UK doctor who supports a consultant) SPR Society for Psychical Research SPR Stop Prisoner Rape array chip applications for high-throughput proteomics analysis." (Reuters: BCOR.N) Notes to editors: Biacore is a global market leader in affinity-based biosensor A device that detects and analyzes body movement, temperature or fluids and turns it into an electronic signal. See lab on a chip and data glove. Biosensor technology with its own sales operations in the U.S., across Europe, in Japan, Australia and New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. . The technology is protected by a strong patent portfolio. Target groups consist primarily of medical and life science research laboratories and pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. all over the world. Biacore focuses on drug discovery as the prime area for future growth. Based in Uppsala, Sweden, the company is listed on the OM Stockholm Exchange and Nasdaq in the U.S. In 1999 the company had sales of SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 340.4 million and an operating income Operating Income The profit realized from a business' own operations. Notes: This would not include income from things such as investments in other firms. Also referred to as operating profit or recurring profit. of SEK 67.6 million. Further information on Biacore can be found on the web: www.biacore.com Address and phone: Biacore International AB Rapsgatan 7, SE-754 50 Uppsala, SWEDEN Phone: +46 (0)18-675700 Fax: +46 (0)18-150111 info@biacore.com This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2000/08/14/20000814BIT00450/bit0001.doc http://www.bit.se/bitonline/2000/08/14/20000814BIT00450/bit0002.pdf |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion